Aug 13, 2020
Calliditas Announces Agreement to Acquire Controlling Interest in Genkyotex SA
Feb 06, 2020
PharmaNest Announces Kidney and Lung Fibrosis Quantification Data to Be Presented at the 2020 Fibrosis and Tissue Repair Keystone Symposium
Jan 13, 2020
Soliton To Announce Keloid and Hypertrophic Scar Clinical 12-Week Trial Data at Maui Derm Meeting
Nov 21, 2019
Enzychem Lifesciences Presents EC-18 NASH Development Update at The Liver Meeting 2019
Oct 29, 2019
Soliton's Recent Positive Data Increases Potential Fibrotic Indications
Oct 02, 2019
Xylyx Bio announces development of disease-specific cell culture products to accelerate anti-fibrotic drug discovery and screening
Jun 27, 2019
Pliant Therapeutics Reports Positive Results of Phase 1b Clinical Study Supporting Advancement of PLN-74809 for Treatment of Idiopathic Pulmonary Fibrosis
Apr 10, 2019
Synspira Therapeutics Receives Orphan Designation for SNSP113 for the Treatment of Cystic Fibrosis in the European Union
Apr 09, 2019
Pliant Therapeutics Reports Positive Results of Phase 1 Clinical Study Support Advancement of PLN-74809 for Idiopathic Pulmonary Fibrosis
Mar 28, 2019
Pliant Therapeutics Presents Data in Human NASH Liver Tissue at The International Liver Congress 2019 Hosted by the European Association for the Study of the Liver (EASL)
Mar 20, 2019
Access To Care Improves For Patients With Complex Lung Disease
Jan 03, 2019
Pliant Therapeutics Initiates Phase 1 Clinical Study of PLN-74809
Nov 20, 2018
Pliant Therapeutics Receives FDA Orphan Drug Designation for Lead Program PLN-74809 in Primary Sclerosing Cholangitis
Nov 18, 2018
Bridge Biotherapeutics Files Investigational New Drug Application for BBT-877, an Autotaxin Inhibitor for Idiopathic Pulmonary Fibrosis
Nov 09, 2018
Symic Bio Selected for "The Best of The Liver Meeting 2018" at AASLD
Nov 09, 2018
Pliant Therapeutics Presents Preclinical Data in NASH and PSC at The Liver Meeting 2018
Nov 05, 2018
Combo Cell Therapy Promotes Healing of Cirrhosis-damaged Liver
Aug 06, 2018
Pliant Therapeutics Receives FDA Orphan Drug Designation for Lead Program PLN-74809 in Idiopathic Pulmonary Fibrosis
Jul 23, 2018
OliX, a RNAi therapeutics developer, gets approval for KOSDAQ listing
Jul 16, 2018
Pliant Therapeutics Raises $62 Million in Series B Financing to Advance Therapies for Fibrotic Diseases